Naxicap Partners has acquired Groupe Moria
Naxicap Partners has acquired Groupe Moria from Bridgepoint Development Capital.
Naxicap Partners is a French private equity firm operating in all sectors and focusing on leverage buy-outs and growth capital. For more than 30 years, the firm has invested in ambitious companies in France, Benelux and Spain through controlling majority stakes. As of 31 December 2017, Naxicap Partners manages US$3.5 billion for BPCE Group (33%) and for global institutional investors (67%).
Groupe Moria manufactures and distributes ophthalmic surgery consumables, single use and reusable instruments addressing refractive, corneal, cataract and retinal procedures. The company benefits from strong know-how, combining handcraft capabilities and state-of-the-art technology located in two industrial facilities in France. Present in nearly 80 countries, the group reaches its end customers worldwide through to a tier-2 distribution model (direct sales to surgeons and healthcare facilities and indirect sales via distributors and wholesalers).
Bridgepoint Development Capital is a major international private equity group focused on buy-outs and growth capital investments, typically in businesses with an enterprise value of between US$22–267 million. The firm currently operates in the UK, France and the Nordic region.
Oaklins' team in France advised the buyer in this transaction.
Talk to the deal team
Related deals
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn more